Alfa Cytology Announces Small Molecule Drug Development to Advance Preclinical Cancer Research

Alfa Cytology has announced its small molecule drug development to advance preclinical cancer research. New York, United States, 10th Jul 2024—Alfa Cytology, a comprehensive biotech company specializing in cancer research, has recently announced the cancer …

Alfa Cytology Announces Small Molecule Drug Development to Advance Preclinical Cancer Research Read More

Bioxytran’s BXT-25 Drug Acts as a Universal Oxygen Carrier Like Hyperbaric Oxygenation for Stroke and Alzheimer’s Patients

BXT-25 is expected to oxygenate the brain and be monitored by Bioxytran’s FDA approved medical device to trace all oxygen molecules BOSTON, MASSACHUSETTS, July 8, 2024 (GLOBE NEWSWIRE) — BIOXYTRAN, …

Bioxytran’s BXT-25 Drug Acts as a Universal Oxygen Carrier Like Hyperbaric Oxygenation for Stroke and Alzheimer’s Patients Read More